Literature DB >> 30600027

Stability of cationic and amphoteric derivatives of mannan from the yeast Candida albicans.

Alžbeta Čížová1, Katarína Csomorová2, Jozef Rychlý3, Slavomír Bystrický4.   

Abstract

Infection with Candida albicans can prove lethal in immuno-compromised patients. It is imperative to develop a vaccine against this common organism. The amphoteric derivatives of the mannan component of the Candida cell wall may present a prospective target for the development of such a vaccine; however, the radical processing by antigen-presenting cells of the immune system is not fully understood. In this work a set of tailor-made cationic and amphoteric derivatives of three different degrees of quaternization (DSQ 0.14-0.38) has been prepared by chemical modification of ultrasonically-treated mannan and three carboxymethylated mannan derivatives (DSCM 0.13-0.32). These were exposed to free-radical attack by OH, generated in situ by the Fenton reaction. Potential changes in composition, DSQ, and molar mass distribution due to free-radical degradation were monitored by elemental analysis, NMR and FTIR spectroscopies, and size exclusion chromatography. A protective effect of quaternization against OH degradation was found. Non-isothermal thermogravimetric analysis found that the thermal stability of this mannan was also improved by chemical modification.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amphoteric; Candida albicans; Cationic; Degradation; Free-radical; Mannan

Mesh:

Substances:

Year:  2018        PMID: 30600027     DOI: 10.1016/j.carbpol.2018.11.101

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  1 in total

1.  Candida albicans CHK1 gene regulates its cross-kingdom interactions with Streptococcus mutans to promote caries.

Authors:  Yaqi Liu; Zheng Wang; Ziyi Zhou; Qizhao Ma; Jing Li; Jun Huang; Lei Lei; Xuedong Zhou; Lei Cheng; Jing Zou; Biao Ren
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-05       Impact factor: 5.560

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.